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Given the shortage of caregivers and the increase in an aging US population, the future of US healthcare
quality does not look promising and definitely is unlikely to be cheaper. Advances in health information
systems and healthcare technology offer a tremendous opportunity for improving the quality of care while
reducing costs.
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advances in healthcare delivery. A critical concern, how-
ever, is the cost-effective development and production
of reliable and safe medical device software and systems.
MEDICAL DEVICE SOFTWARE AND SYSTEMS
The development and production of medical device
software and systems is a crucial issue, both for the US
economy and for ensuring safe advances in healthcare
delivery. As devices become increasingly smaller in phys-
ical terms but larger in software terms, the design, test-
ing, and eventual Food and Drug Administration (FDA)
device approval is becoming much more expensive for
medical device manufacturers both in terms of time and
cost. Furthermore, the number of devices that have
recently been recalled due to software and hardware
problems is increasing at an alarming rate. As medical
devices are becoming increasingly networked, ensuring
even the same level of health safety seems a challenge.
Several federal and regulatory agencies have identi-
fied this growing problem and are interested in estab-
lishing a research agenda directed at improving the
design, certification, and operation of current and future
medical device software and systems. The 2005 High-
Confidence Medical Device Software and Systems
(HCMDSS) workshop was sponsored by various fed-
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T he United States spends about 16 percent of itsgross domestic product on healthcare, twice theaverage of most European nations.1 Given theshortage of caregivers and the increase in anaging US population, the future of US health-
care quality does not look promising and definitely does
not look cheaper. Advances in health information sys-
tems and healthcare technology offer a tremendous
opportunity for improving the quality of our healthcare
while reducing healthcare costs. 
Advances in computing, networking, sensing, and
medical device technology are enabling the dramatic
proliferation of diagnostic and therapeutic devices.
These devices range from advanced imaging machines
to minimally invasive surgical techniques, from camera
pills to doctor-on-a-chip, from computerized insulin
pumps to implantable heart devices. 
Although advances in stand-alone diagnostic and
treatment systems have been accelerating steadily, the
lack of proper integration and interoperation of those
systems produces systemic inefficiencies in healthcare
delivery. This inflates costs and contributes to avoidable
medical errors that degrade patient care. The use of soft-
ware that controls medical devices to overcome these





eral agencies, including the FDA, the National Institute
of Standards and Technology, the National Security
Agency, and the National Science Foundation, along
with the National Coordination Office for Networking
and Information Technology Research and
Development. The views expressed in this article are
those of the authors, and not necessarily those of the
federal sponsors.
The purpose of the HCMDSS workshop was to pro-
vide a working forum for leaders and visionaries from
industry, research laboratories, academia, and govern-
ment concerned with medical devices. More than 90
experts from these sectors attended
the workshop. They represented a
mix of the relevant stakeholders—
including researchers, developers,
certifiers, and users—who can help
identify emerging systems and assur-
ance needs. 
This workshop’s main goal was to
develop a road map for overcoming
crucial issues and challenges facing
the design, manufacture, certifica-
tion, and use of medical device software and systems.
An additional goal was to identify and form a sustain-
able research and development community for the
advancement of HCMDSS. Of particular interest was
the crystallization of technology needs and promising
research directions that could revolutionize the way
HCMDSS are designed, produced, and validated in the
future but that are beyond the range of today’s devices
because of time-to-market pressures and short-term
R&D practices. The presentations of the working
groups, keynote speakers, and panelists and the sub-
mitted position statements of participants in this work-
shop are available at www.cis.upenn.edu/hcmdss/.
CRITICAL ISSUES 
In the course of this workshop, the participants iden-
tified six issues as critical for the future of high-confi-
dence medical devices:
• Foundations for integrating medical device systems.
Commercial off-the-shelf technologies do not pro-
duce highly distributed medical device systems with
guarantees of security, privacy, robustness, interop-
erability, extensibility, mobility, and general patient
safety. Advances in computing are instrumental in
the development of novel diagnostic and therapeu-
tic equipment and procedures and of widely acces-
sible medical-record systems. Although diagnostic
and treatment systems have advanced significantly,
they do not work well together. The systemic ineffi-
ciencies in healthcare delivery grossly inflate costs
and contribute to avoidable medical errors that
degrade patient care.
• Distributed control and sensing in networked med-
ical device systems. The networking of medical
devices for distributed sensing and control can occur
at many levels. These networks can collect data for
offline analysis, generate alarms when critical condi-
tions occur, or close feedback loops for the controlled
delivery of drugs. Research is needed to create med-
ical device networks with these features and to enable
the diffusion of new sensing and control technologies
as they become available.
• Patient modeling and simulation. Modeling has
proved its value in many industries, such as aerospace,
automotive, and chemical plants. It
has fostered novel product develop-
ment, increased safety parameters,
and ensured cost-effective develop-
ment phases, ultimately achieving 
regulatory approval. In the medical-
practice domain, modeling and simu-
lation will improve outcomes and
quality of patient care, will provide
better control of healthcare costs with
improvements in prevention and
intervention, and will allow maximal use of the elec-
tronic health records. 
• Embedded real-time networked system infrastructure.
Researchers envision next-generation medical systems
to be a ubiquitous network of networked systems that
provides secure, reliable, privacy-preserving, and cost-
effective, personalized, high-quality healthcare.
Although networks of networked medical devices
hold many promises and possibilities, they also create
challenges.
• Medical device software development. Many medical
devices are, essentially, embedded systems. As such,
software is often a fundamental—albeit not always
obvious—part of a device’s functionality. This means
that any safety and regulatory requirements for med-
ical devices necessarily call for rigorous software
development methods to ensure reliability and to pro-
tect the public health. Exactly how to accomplish that
is a question, particularly because devices and systems
are becoming increasingly complicated and intercon-
nected. We have reached the point where testing as
the primary way to gain confidence in a system is
impractical or ineffective. Furthermore, requirements
and specifications based on medical practice are
needed to help ensure that devices will perform appro-
priately.
• Validation and certification. Verification and valida-
tion tasks required for the approval of medical devices
play a significant role in enabling the FDA to carry
out its mandate of approving only “safe and effec-
tive” medical devices. Unfortunately, many industry
observers believe that we are approaching the limits
of current device certification processes. As devices
Although networks of
networked medical devices
hold many promises 
and possibilities, they also 
create challenges.
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grow more complex and rely much more on embed-
ded software to achieve critical functionality, existing
certification processes are being stressed. This trend
results in higher development costs for manufacturers,
longer time to market, and increased chances of device
failure—with associated recall or liability costs.
CURRENT STATE OF AFFAIRS 
Each working group summarized the state of the
practice, development, and research in its area, identified
R&D needs and challenges, and provided a road map to
address their needs and challenges. 
Several observations were made about the state of the
art in medical device software and system development:
• Medical device software development. As a whole,
the medical industry does reasonably well in de-
veloping and approving stand-
alone devices that have moder-
ate complexity and are based 
on mature technology. In such
cases, the domain is well under-
stood and the technology fur-
nishes examples of devices that
have been approved. However,
designing bug-free software is
difficult, especially in complex
devices that might be used in
unanticipated contexts. Existing
practices have worked as well as they have because
industry verification and validation personnel and
regulators take their jobs seriously.
• Large-scale, complex devices stress current best prac-
tices. We are still challenged by large-scale, complex
devices, such as proton therapy facilities. For these
types of devices, the validation procedures and test
cases can number in the hundreds of thousands. The
burden of validation—in time and costs—extends the
time to bring devices to market. Because of time-to-
deliver pressures and a shortfall in properly trained
software engineers, the development of HCMDSS
has—with few exceptions—not kept pace with soft-
ware assurance techniques practiced in other safety-
critical domains such as avionics.
• Integration of MDSS. Industry is doing fairly well
at integrating products developed by a single man-
ufacturer. Such integrations are largely proceeding
in an ad hoc fashion, however, without standard-
ized integration mechanisms that are commonplace
in other domains, such as the highly successful and
widely used universal serial bus from the personal-
computer domain. Because the number of medical
devices and systems that are to be networked and
integrated is increasing significantly, we must
develop standards and regulations for medical
device integration.
• Device interference and interoperation. Caregivers
and clinical engineers report that as devices prolifer-
ate and as sophistication and connectivity in hospi-
tals increase, we are becoming lost in a swirl of
technology, and we face unanticipated interference
between devices. A concerted effort to address inter-
operability has begun, aiming to develop plug-and-
play interoperability standards for the operating room
of the future. So far the main concern has been net-
work standards; other essential issues, such as qual-
ity of service and semantic compatibility for
interoperation, have not yet been addressed. Also, we
need to conduct a systematic study of device inter-
ference during integration.
• Certification. FDA device approval relies on a
process-driven approach, in which manufacturers
obtain approval by showing that they have applied
established quality assurance tech-
niques to certain levels of coverage,
using manual code inspections. In
particular, collective knowledge and
experience within large, well-estab-
lished companies aid the effort nec-
essary to prepare for the market. But
when considering larger devices
with relatively complex functional-
ity, the time and costs associated
with verification and validation
tasks such as test generation and
execution cause researchers to lose confidence in
their ability to bring safe and effective devices to
market.
We must also consider the effectiveness and already
high costs of development and certification processes in
the context of rapid advances in technology that have
fundamentally changed the way many informational,
financial, and scientific services are provided. 
Although technological advances have contributed to
a steady increase in the quality of healthcare, and
although FDA approval processes have for the most part
been able to keep pace, we now seem to be on the cusp
of the types of revolutionary changes in healthcare sys-
tems that have transformed other sectors of the nation’s
infrastructure and economy. Such changes call for a par-
adigm shift in the development and certification of med-
ical device software and systems.
For example, pervasive networking will enable the inte-
gration of national networks, regional healthcare centers,
local hospitals and clinics, the offices of primary-care
physicians, home computing, and body-area networks.
The healthcare IT infrastructure will focus on “systems of
systems” that integrate and blend monitoring and treat-
ment devices. Networks will stream data into medical
records that are automatically mined to extract the
knowledge used to drive a host of activities, such as auto-
We now seem to be on the cusp
of the types of revolutionary
changes in healthcare systems
that have transformed other 
sectors of the nation’s 
infrastructure and economy.
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mated treatment and dosing and long-term research into
human health and the effectiveness of treatment.
For healthcare providers, operating rooms and diag-
nosis and treatment venues will shift from a collection
of fixed monolithic devices to plug-and-play components
that enable flexible and rapid reconfiguration of diag-
nostic, recording, and treatment systems. Advances in
minimally invasive medical robotics and real-time high-
speed networks will make telemedicine and robotic
surgery technologies widely available. As generations of
technology-savvy healthcare consumers enter retire-
ment, they will embrace—and even demand—sophisti-
cated home healthcare monitoring,
treatment, and record systems inte-
grated with national information
databases (such as prescription-drug
information systems) and local hos-
pital and primary-care systems.
Although these envisioned inno-
vations hold great promise, they will
render current MDSS development
and certification processes obsolete.
End-user demands inevitably exceed
the capability of existing MDSS.
Unless researchers develop new certification technolo-
gies and unless development and certification processes
undergo a paradigm shift, innovation will be stifled
because manufacturers and regulators will find the
development of HCMDSS too costly—or we will see
dramatic increases in security breaches and harmful inci-
dents due to device malfunction.
CHALLENGES
The cross-cutting nature of medical device design—
transcending the informational, physical, and medical
worlds—along with the possibility of a nationwide net-
worked medical system that actively monitors and reg-
ulates the health of our nation’s citizens, raises immense
scientific and technological R&D challenges for the IT,
medical, and regulatory communities. The challenges
envisioned for the next 10 years include the following:
• System integration. As we embrace a plug-and-play
vision of medical device networks in future digital
hospitals and digital homes, we must collectively
facilitate the development of medical device systems
and coordinate them with the development of stan-
dards for the architecture and communication of
interoperable plug-and-play device networks.
Achieving these goals while establishing quality-of-
service levels that ensure system and patient safety on
the one hand, and patient security and privacy on
the other, is a great challenge.
• Critical infrastructure. As we move toward an envi-
ronment in which all patients are constantly moni-
tored and actively plugged into a nationwide medical
information network, we are creating a new critical
infrastructure that will literally monitor the nation’s
health. We need new methods to ensure the safety and
security of that network, particularly methods involv-
ing the active use of information for medical purposes.
In the presence of abnormal conditions or attacks, the
system’s performance must degrade gracefully and
safely, and the system must identify, contain, and, if
possible, repair faults while providing timely notifi-
cation to human operators.
• Embedded real-time systems design. Medical devices
are embedded not only inside information networks
but also inside human patients,
whose critical life-functions they
monitor and regulate. The design of
medical devices is therefore more
than an IT issue; it must also include
the device’s interaction with the
patient and the environment and the
context in which they coexist. Thus,
we need a fundamental rethinking
of medical device design—toward a
holistic approach that integrates
functional, computational, and com-
munication designs in the presence of highly uncer-
tain patient models in both normal and abnormal
conditions.
• Validation and certification. Current design prac-
tice makes certification and verification an after-
thought, taking place at the end of the design cycle,
when it is frequently too late to change design
choices. As medical devices become more complex
and more interconnected, it is becoming increas-
ingly evident that certification should be incorpo-
rated in early design stages. Furthermore, certifica-
tion and design frameworks are currently not com-
ponent-based, resulting in time-consuming and
expensive certification of large integrated systems,
inefficient certification of incremental or evolution-
ary designs, and difficulties in maintaining or
upgrading legacy systems.
Addressing these challenges will dramatically affect
the medical device and healthcare industry with signif-
icant system integration and development capabilities
based on scientific principles and foundations. 
RESEARCH DIRECTIONS
Despite the nationwide scale and the heterogeneous
nature of the R&D challenges, the following research
directions will help us make significant progress toward
realizing the outlined challenges.
• Infrastructure for medical device integration and
interoperation. The Electronic Health Records ini-
tiative needs to be safely and securely integrated with
The cross-cutting nature 
of medical device design 
raises immense scientific and
technological R&D challenges
for the IT, medical, and
regulatory communities.
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plug-and-play interoperable device networks so that
we can fully realize the vision of actively using
patient-specific information in optimum health deliv-
ery via interoperable medical devices. Interoperability
presents a major challenge to integrating medical
devices from different manufacturers. It will require
the development of standards and architectures not
only for medical records but also for devices that
actively use that information to monitor and regu-
late patients’ medical conditions. Besides unique
patient (record) identifiers, which must support the
integration of devices from different manufacturers,
standards must address data and
communication formats as well
as the context and environment
assumptions in which the infor-
mation will be interpreted and
used.
• Model-based development. The
multifaceted nature of designing,
implementing, and certifying
medical devices requires holistic
frameworks that are simultane-
ously model-based and compo-
nent-based. Because of the strong coupling between
device and patient, model-based frameworks that
explicitly model a device’s interaction with the envi-
ronment and with the patient would lead to safer,
higher-confidence devices and ultimately to better
healthcare.
• Component-based design frameworks. Despite sub-
stantial progress in object-oriented frameworks for
nonembedded software, model-based development
is a challenging research direction. Component-based
development will dramatically affect both the design
and certification process: It will enable incremental
yet certified compositions of certified components,
allowing the safe and rapid reuse of legacy compo-
nents—models, software, and algorithms. Our goal
should be to develop frameworks in which certifica-
tion is part of the design process rather than an after-
thought. Component-based design should also
support a variety of standards for communication
and security.
• Patient modeling and simulation. Medical devices face
a unique challenge in model-based design because of
the scarcity of patient models and high-fidelity simu-
lators for device design. As future devices adapt to
patients, their medical conditions, and their environ-
ment, developing a variety of models and simulators
for normal and abnormal patients in a variety of phys-
ical and environmental conditions will be increasingly
important. We must develop models and simulators
at various levels of detail, ranging from coarse mod-
els for device design to high-fidelity simulators for
model validation and virtual validation and testing.
• Adaptive patient-specific algorithms. Whereas med-
ical devices are typically designed for groups of
patients who have similar medical conditions, we
could dramatically improve healthcare by making
devices whose operation would adapt to a specific
patient’s specific medical condition. To achieve that,
we need to develop control, optimization, and
machine-learning algorithms for medical devices that
are certifiably safe for large classes of patients and
that can adapt to individual patients or to different
environments.
• Requirements and metrics for certifiable assurance
and safety. Developing rigorous
requirements for clinical and design
purposes, as well as metrics for certi-
fiable assurance, is an important
research direction. In particular, for-
malizing requirements will enable
precise and transparent translation
of natural-language clinical require-
ments to quantified engineering
requirements. It will also affect test-
ing by developing frameworks for
generating testing scenarios from
clinical requirements.
• User-centered design. As medical devices perme-
ate cross-sections of society and all educational
and technical backgrounds, ergonomics and ease-
of-use issues become important design factors in
human-device interfaces. These issues should be
considered throughout the design process. User
and context modeling will result in better interac-
tion between users and devices, minimize unsafe
device operation, and result in graceful degrada-
tion of performance in the event of user or device
failures.
Achieving this grand agenda is not simply a matter of
time. It requires synergistic and concerted efforts among
healthcare practitioners, medical device developers and
manufacturers, and academics from the computer sci-
ence, control theory, and bioengineering disciplines.
Furthermore, it needs planning and support from gov-
ernment agencies.
T o initiate this research agenda, medical device man-ufacturers must provide open experimental plat-forms to the academic community, and the
regulating agencies must better educate everyone about
the current medical device approval process. Under-
standing the approval process along with formalization
of clinical and user-centered design requirements will be
critical for subsequently developing quantifiable metrics
for system assurance and certification. Standards for
data, information, and communication will enable plug-
Formalizing requirements 
will enable precise and





and-play, interoperable device networks operating on
robust real-time infrastructures. 
It is becoming increasingly evident that model-based
frameworks that support component-based modeling,
design, testing, and certification can have a dramatic
impact. The one aspect of this agenda that might require
a longer horizon, however, is the development of high-
fidelity organ and patient models for design, testing, and
validation. 
This agenda has the potential to create a new scien-
tific community and a new generation of scientists and
engineers that integrate computer science, engineering,
and medicine. ■
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